Product custom-nanocomposites-fluorescent-labeled-nanocomposites

Home > products > custom-nanocomposites> fluorescent-labeled-nanocomposites

Catalog	name	Description	price
R-Mcs-200	DOTAP:DOPC:Chol:DSPE-N-DBCO(5:64:30:1molar ratio)-based Fluoroliposome Cyanine 7 lipid-DBCO	DOTAP:DOPC:Chol:DSPE-N-DBCO(5:64:30:1molar ratio)-based Fluoroliposome Cyanine 7 lipid-DBCO is a DOTAP-based Fluoroliposome-DBCO for Tracking and Detection.The cationic DOTAP lipid can enhance cellular uptake for therapeutic agents (drugs, nucleotides).Cy7-lipids provide optical contrast for imaging in biological systems. DSPE-N-DBCO allows for functionalization through click chemistry to target specific cells or tissues.	price>
R-Mcs-201	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiA-DBCO	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiA-DBCO is a DOTAP-based Fluoroliposome-DBCO for Tracking and Detection. The DOPG:DOPC:Chol:DOPE-N-DBCO (20:49:30:1) for fluorescence-based applications, drug delivery, and targeting specific tissues or cells. The combination of lipid components ensures stability, fluidity, and interaction capabilities, making it suitable for various biomedical applications. Further functionalization with fluorescent markers via the DBCO moiety expands its utility in research and clinical settings.	price>
R-Mcs-202	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiD-DBCO	The formulation of DOPG:DOPC:Chol:DOPE-N-DBCO (20:49:30:1) with DiD-DBCO provides a versatile platform for creating Fluoroliposomes suitable for advanced imaging and drug delivery applications. The careful balance of lipids ensures stability, fluidity, and the potential for targeted delivery, while the fluorescent tagging allows for detailed monitoring of therapeutic actions and cellular interactions. This makes these liposomes an exciting tool for both research and clinical applications in biotechnology and medicine.	price>
R-Mcs-203	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiI-DBCO	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiI-DBCO in drug delivery, cellular imaging, and biomedical research. This system not only allows for effective cellular uptake and therapeutic release but also enables real-time tracking through fluorescence, making it a powerful tool for both academic and clinical research settings.	price>
R-Mcs-204	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiO-DBCO	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiO-DBCO for cellular imaging and targeted drug delivery. By modifying the exterior of the liposomal formulation with ligands that can bind specifically to cell surface receptors, these liposomes can be designed for targeted drug delivery applications, which is especially beneficial in cancer therapy.Fluoroliposomes can be used to deliver various therapeutic agents, including small molecule drugs, genes, or proteins, providing a means for targeted treatment while minimizing side effects.	price>
R-Mcs-205	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiR-DBCO	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiR-DBCO for cellular imaging and targeted drug delivery. By modifying the exterior of the liposomal formulation with ligands that can bind specifically to cell surface receptors, these liposomes can be designed for targeted drug delivery applications, which is especially beneficial in cancer therapy.Fluoroliposomes can be used to deliver various therapeutic agents, including small molecule drugs, genes, or proteins, providing a means for targeted treatment while minimizing side effects.	price>
R-Mcs-206	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Dansyl lipid (headgroup)-DBCO	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Dansyl lipid (headgroup)-DBCO for cellular imaging and targeted drug delivery. By modifying the exterior of the liposomal formulation with ligands that can bind specifically to cell surface receptors, these liposomes can be designed for targeted drug delivery applications, which is especially beneficial in cancer therapy.Fluoroliposomes can be used to deliver various therapeutic agents, including small molecule drugs, genes, or proteins, providing a means for targeted treatment while minimizing side effects.	price>
R-Mcs-207	DOPG:DOPC:Chol:DOPE-N-DBCO-based Fluoroliposome NBD lipid (fatty acid tail)-DBCO	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome NBD lipid (fatty acid tail)-DBCO for cellular imaging and targeted drug delivery. By modifying the exterior of the liposomal formulation with ligands that can bind specifically to cell surface receptors, these liposomes can be designed for targeted drug delivery applications, which is especially beneficial in cancer therapy.Fluoroliposomes can be used to deliver various therapeutic agents, including small molecule drugs, genes, or proteins, providing a means for targeted treatment while minimizing side effects.	price>
R-Mcs-208	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome NBD lipid (headgroup)-DBCO	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome NBD lipid (headgroup)-DBCO for cellular imaging and targeted drug delivery. By modifying the exterior of the liposomal formulation with ligands that can bind specifically to cell surface receptors, these liposomes can be designed for targeted drug delivery applications, which is especially beneficial in cancer therapy.Fluoroliposomes can be used to deliver various therapeutic agents, including small molecule drugs, genes, or proteins, providing a means for targeted treatment while minimizing side effects.	price>
R-Mcs-209	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Pyrene lipid (headgroup)-DBCO	DOPG:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Pyrene lipid (headgroup)-DBCO can be utilized for real-time imaging of cellular uptake, tracking the biodistribution of liposome formulations in vivo. The distinct fluorescence of pyrene enables high sensitivity in detection.The DBCO group can be utilized for precise targeting through bioorthogonal chemistry, enabling specific attachment to antibodies, peptides, or other molecules that direct the liposomes to particular cells or tissues, such as tumors.Fluoroliposomes with pyrene can be applied in building biosensors to detect specific biomolecules or environmental changes (e.g., pH, ion concentration) based on changes in fluorescence.	price>

...